You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab

 

Online download statistics by month:

Online download statistics by month: July 2021 to November 2024

AbstractFullPdf
Jul 2021593597226
Aug 202125024956
Sep 202115915952
Oct 202115815844
Nov 202110610843
Dec 2021878720
Jan 202210310740
Feb 2022626325
Mar 2022626224
Apr 2022606215
May 20229910232
Jun 2022879632
Jul 2022646419
Aug 2022979717
Sep 2022858933
Oct 2022586223
Nov 2022606027
Dec 2022424218
Jan 2023434412
Feb 2023626319
Mar 202310911141
Apr 2023939357
May 202315215351
Jun 202312312317
Jul 202311811828
Aug 2023949424
Sep 2023969632
Oct 2023525211
Nov 2023747429
Dec 2023707014
Jan 2024565724
Feb 2024606017
Mar 2024515189
Apr 2024383825
May 2024353624
Jun 2024302914
Jul 2024474827
Aug 2024383718
Sep 2024414119
Oct 2024555619
Nov 2024707514
Total383938831371